The American Journal of Surgery
Volume 196, Issue 2 , Pages 160-169 , August 2008

Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience

  • Manousos M. Konstadoulakis, M.D., Ph.D.

      Affiliations

    • Recanati-Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +011-30-6972241980; fax: +1-30-210-6722259.
    • ,
  • Sasan Roayaie, M.D.

      Affiliations

    • Recanati-Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    • ,
  • Ilias P. Gomatos, M.D.

      Affiliations

    • First Department of Propaedeutic Surgery, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    • ,
  • Daniel Labow, M.D.

      Affiliations

    • Recanati-Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    • ,
  • Maria-Isabell Fiel, M.D.

      Affiliations

    • Department of Pathology, Mount Sinai Medical Center, New York, NY, USA
    • ,
  • Charles M. Miller, M.D.

      Affiliations

    • Recanati-Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece
    • ,
  • Myron E. Schwartz, M.D.

      Affiliations

    • Recanati-Miller Transplantation Institute, Hippocration Hospital of Athens, Athens Medical School, Athens, Greece

Received 5 April 2007 ,Revised 12 July 2007

References 

  1. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative surgery, and a presurgical clinical staging system. Ann Surg. 1998;228:385–394
  2. Fong Y, Blumgart LH, Lin E, et al. Outcome of treatment for distal bile duct cancer. Br J Surg. 1996;83:1712–1715
  3. Nagorney DM, Donohue JH, Farnell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg. 1993;128:871–877
  4. Pichlmayr R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg. 1995;19:83–88
  5. Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma: postsurgical radiotherapy does not improve survival. Ann Surg. 1995;221:788–797
  6. Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84–92
  7. Baer HU, Stain SC, Dennison AR, et al. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg. 1993;217:20–27
  8. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–178
  9. Extrahepatic bile ducts. In:  Greene FL editors. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed.. New York, NY: Springer; 2002;p. 145–150
  10. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer (A single-center experience). Ann Surg. 1996;224:628–638
  11. Tashiro S, Tsuji T, Kanemitsu K, et al. Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery. 1993;113:270–278
  12. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995;130:270–276
  13. Lai EC, Chu KM, Lo CY, et al. Choice of palliation for malignant hilar biliary obstruction. Am J Surg. 1992;163:208–212
  14. Nordback IH, Pitt HA, Coleman J, et al. Unresectable hilar cholangiocarcinoma: percutaneous versus surgical palliation. Surgery. 1994;115:597–603
  15. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg. 1999;230:266–275
  16. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–727
  17. Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postsurgical mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95–101
  18. Baton O, Azoulay D, Adam DV, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and long-term outcomes. J Am Coll Surg. 2007;204:250–260
  19. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–458
  20. Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75:981–985
  21. Zervos EE, Osborne D, Goldin SB, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive surgical approach. Am J Surg. 2005;190:810–815
  22. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–702
  23. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg. 2004;139:514–523
  24. Uchiyama K, Nakai T, Tani M, et al. Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma. Arch Surg. 2003;138:1012–1016
  25. Capussotti L, Muratore A, Polastri R, et al. Liver resection for hilar cholangiocarcinoma: in-hospital mortality and long-term survival. J Am Coll Surg. 2002;195:641–647
  26. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–517
  27. Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7:155–162
  28. Sakamoto E, Nimura Y, Hayakawa N, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405–411
  29. Shimada K, Sano T, Sakamoto Y, et al. Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg. 2005;29:723–727
  30. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–458
  31. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant. 2002;2:774–779
  32. Pichlmayr R, Ringe B, Lauchart W, et al. Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg. 1988;12:68–77
  33. Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in hepatobiliary malignancy (A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence). Ann Surg. 1989;209:88–98
  34. Su CH, Tsay SH, Wu CC, et al. Factors influencing postsurgical morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223:384–394
  35. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection. Ann Surg. 2001;233:385–392
  36. Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg. 1999;189:575–583
  37. Munoz L, Roayaie S, Maman D, et al. Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg. 2002;9:237–241

PII: S0002-9610(08)00192-X

doi: 10.1016/j.amjsurg.2007.07.033

The American Journal of Surgery
Volume 196, Issue 2 , Pages 160-169 , August 2008

Article Tools

* Image Usage & Resolution